Author:
BOOK ALISON P.,FIDEL JANEAN,WILLS TAMARA,BRYAN JEFFREY,SELLON RANCE,MATTOON JOHN
Reference53 articles.
1. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical incision;London;Clin Cancer Res,2009
2. Outcomes of dogs with grade 3 mast cell tumors;Hume;43 cases (1997-2007),2011
3. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours;Rassnick;Vet Comp Oncol,2010
4. Efficacy of vinblastine for treatment of canine mast cell tumors;Rassnick;J Vet Intern Med,2008
5. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour;Thamm;61 cases,2006
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献